Domino liver transplantation for maple syrup urine disease in children: A single‐center case series

Abstract

AbstractBackgroundDomino liver transplant (DLT) represents another type of liver donor to expand the donor pool. Recent reports of successful DLT in children with maple syrup urine disease (MSUD) show promising long‐term outcomes.MethodsIt was a retrospective study. All children with MSUD were paired with either recipients with end‐stage liver disease (ESLD) or non‐MSUD metabolic disease. Each pair underwent simultaneous liver transplant (LT), where the MSUD recipient received the graft from a living‐related donor and the liver explanted from the MSUD donor was transplanted to the respective paired domino recipient. We report our experience regarding the techniques and outcomes of DLT at our center.ResultsEleven children with MSUD and 12 respective DLT recipients were enrolled, one of which was domino split‐liver transplantation. DLT recipients included seven ESLD, two propionic acidemia (PA), one glycogen storage disease(GSD) type‐1, one GSD type‐3, and one Citrullinemia. Post‐LT ICU and hospital stays were comparable (p > .05). Patient and graft survival was 100% and 66.6% in the MSUD group and DLT recipients at a mean follow‐up of 13.5 and 15 months. There was no death in the MSUD group as compared to four in the DLT group. The amino acid levels rapidly normalized after the LT in the children with MSUD and they tolerated the normal unrestricted diet. No vascular, biliary, or graft‐related complications were seen in the post‐transplant period. No occurrence of MSUD was noted in DLT recipients.ConclusionDLTs have excellent post‐surgical outcomes. DLT should be strongly considered and adopted by transplant programs worldwide to circumvent organ shortage.